Berenberg analyst Tom Jones lowered the firm’s price target on Grifols (GRFS) to EUR 15.25 from EUR 15.40 and keeps a Buy rating on the ...

In a report released yesterday, Tom Jones from Berenberg Bank maintained a Buy rating on Grifols (0RDU – Research Report), with a price target ...

The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust ...

In other news, the Expansión newspaper reports today that Scranton Enterprises, a Dutch company through which the Grifols family controls part of its investments, managed to carry out a series of ...

This page uses Cookies. For proper functioning of the page Cookies are needed. You agree to using Cookies by clicking "OK". More infos can be found in our Privacy declaration . If you disagree this ...

The selective Spanish stock market, the IBEX 35, continues to extend gains and is already up 0.80% at noon, standing above 12 ...

AstraZeneca and Sartorius were named as the Morgan Stanley analysts' "top picks" in the pharmaceutical sector.

Plasma Fractionation Market Share 2025 Plasma fractionation is a process of separating various components of plasma, which in turn is a com ...

Rising Incidence of Hemophilia, Immunological Disorders, and the Growing Number of Surgical Procedures Worldwide is Driving Growth, at a CAGR of ~9%Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The "Blood ...

Spanish plasma-derived medicines specialist Grifols revealed it is collaborating with Dutch biotechnology start-up, FcR ...